These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11994024)

  • 1. Potential savings from splitting newer antidepressant medications.
    Cohen CI; Cohen SI
    CNS Drugs; 2002; 16(5):353-8. PubMed ID: 11994024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
    Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
    J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cost savings from pill splitting of newer psychotropic medications.
    Cohen CI; Cohen SI
    Psychiatr Serv; 2000 Apr; 51(4):527-9. PubMed ID: 10737832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of pill splitting to achieve cost savings.
    Stafford RS; Radley DC
    Am J Manag Care; 2002 Aug; 8(8):706-12. PubMed ID: 12212758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splitting antidepressant medications: more studies are needed to confirm clinical outcomes and potential savings.
    Donoghue J
    CNS Drugs; 2002; 16(5):359-60. PubMed ID: 11994025
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of antidepressant prescribing concentration to treatment duration and cost.
    Hodgkin D; Merrick EL; Hiatt D
    J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program.
    Vuchetich PJ; Garis RI; Jorgensen AM
    J Am Pharm Assoc (2003); 2003; 43(4):497-502. PubMed ID: 12952314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practice of splitting tablets: cost and therapeutic aspects.
    Bachynsky J; Wiens C; Melnychuk K
    Pharmacoeconomics; 2002; 20(5):339-46. PubMed ID: 11994043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program.
    Choe HM; Stevenson JG; Streetman DS; Heisler M; Sandiford CJ; Piette JD
    Am J Manag Care; 2007 Jun; 13(6 Part 1):298-304. PubMed ID: 17567227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
    Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
    J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased use of antidepressants in Canada: 1981-2000.
    Hemels ME; Koren G; Einarson TR
    Ann Pharmacother; 2002 Sep; 36(9):1375-9. PubMed ID: 12196054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of selected pharmacoeconomic analyses of antidepressant therapy.
    Conner TM; Crismon ML; Still DJ
    Ann Pharmacother; 1999 Mar; 33(3):364-72. PubMed ID: 10200863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage of antidepressant medication dispensed in Scotland.
    Patience D
    Health Bull (Edinb); 1997 Sep; 55(5):322-5. PubMed ID: 11769112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant utilization in primary care in a Spanish region: impact of generic and reference-based pricing policy (2000-2004).
    Ubeda A; Cardo E; Sellés N; Broseta R; Trillo JL; Fernández-Llimós F
    Soc Psychiatry Psychiatr Epidemiol; 2007 Mar; 42(3):181-8. PubMed ID: 17235443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs.
    Lam M; Olivier T; Haslam A; Tuia J; Prasad V
    JAMA Oncol; 2023 Sep; 9(9):1238-1244. PubMed ID: 37471095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.